THIS INNOVATION REDUCES THE RISK OF LATEX ALLERGY TO A MAXIMUM
The elimination of allergens and chemical residues from natural rubber latex and sythetic products with a breakthrough new method, MPXX™, is one of the most outstanding achievements of our partner Budev BV.
|
MPXX-VIDEO |
This unique washing technology is to free NRL and sythetic products from allergenic proteins down to unquantifiable levels and chemical residues to undetectable levels.
|
MPXX™ IS ROBUST, PROVEN AND CAN BE EASILY IMPLEMENTED ON LOCATION.
MPXX™ technology has been successfully proven by amongst others the following tests: FITkit ®, RAST- inhibition , Modified Lowry, HPLC , SDS – PAGE, migratable N-nitrosamines, chemical residue test, cytotoxicity.
This combination of tests, unique for the world, not only proves MPXX™ technology to be a breakthrough but also results in the cleanest and highest quality products available. (All test results are available upon request)
Cleantexx -MPXX™ gloves have been awarded the aha! label
by Service Allergy Suisse SA.
NATURAL RUBBER LATEX AND SYNETHETIC MATERIALS ARE USED IN OVER 40.000 DIFFERENT PRODUCTS
In thousands of households as well as in the industrial and medical worlds.
An allergy is a hypersensitive immunologic response to a substance (i.e. allergen) in a genetically predisposed individual. Raw latex for example contains approximately 200 different types of proteins out of which 14 have been identified as allergens. Raw latex based products, as well as synthetic products, further contain chemical residues which can also cause allergy (known as Type IV allergy).
The most common hypersensitivities are Type I (IgE mediated) and Type IV.
IgE = Immunoglobulin E
IgE is a class of immunoglobulin that includes the antibodies elicited by an allergic substance (allergen). These antibodies are produced after contact with an allergen in genetically capable individuals. Once made, IgE antibodies attach to mast cells (in tissues) and basophil cells (in blood) and thereafter mediate allergic diseases such as asthma, hay fever and Type I hypersensitivity.
For any further information please get in contact with us. We will provide detailed and precise technical and commercial information. We will advise on your specific application for this ground breaking technology.
